Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Standard BioTools ( (LAB) ) has provided an announcement.
Standard BioTools reported its financial results for the second quarter of 2025, highlighting a total revenue of $42 million, with $21.8 million from continuing operations. The company announced the strategic sale of SomaLogic to Illumina for up to $425 million, expected to close in the first half of 2026, which will significantly bolster its cash reserves to at least $550 million. This move is part of a broader strategy to streamline operations and focus on profitability by 2026, despite challenges such as reduced U.S. academic spending and global capital constraints. The company is pausing its earnings calls temporarily to focus on operational adjustments.
The most recent analyst rating on (LAB) stock is a Buy with a $2.75 price target. To see the full list of analyst forecasts on Standard BioTools stock, see the LAB Stock Forecast page.
Spark’s Take on LAB Stock
According to Spark, TipRanks’ AI Analyst, LAB is a Neutral.
The overall stock score reflects significant financial challenges, primarily due to persistent losses and high leverage. While technical indicators show moderate strength, valuation concerns persist with a negative P/E ratio. Strategic improvements and corporate events offer some potential for future growth. The company’s ability to improve operational efficiency and profitability will be crucial for enhancing its financial standing.
To see Spark’s full report on LAB stock, click here.
More about Standard BioTools
Standard BioTools Inc. operates in the biotechnology industry, focusing on providing advanced tools and services for scientific research. The company is known for its consumables, instruments, and field services, catering primarily to the academic and research sectors.
Average Trading Volume: 1,887,289
Technical Sentiment Signal: Sell
Current Market Cap: $495.7M
For an in-depth examination of LAB stock, go to TipRanks’ Overview page.